Comment on treatment for recurrent vulvovaginal candidiasis

Am J Obstet Gynecol. 2017 Apr;216(4):426-427. doi: 10.1016/j.ajog.2016.11.1029. Epub 2016 Nov 16.

Authors

Švitrigailė Grincevičienė¹, Gilbert G G Donders²

Affiliations

¹ Department of Biothermodynamics and Drug Design, Vilnius University Institute of Biotechnology, Vilnius, Lithuania; Femicare Clinical Research for Women, Tienen, Belgium. Electronic address: svitrigaile@gmail.com.
² Femicare Clinical Research for Women, Tienen, Belgium; Department of OB/Gyn, Antwerp University, Antwerp, Belgium.

PMID: 27865976
DOI: 10.1016/j.ajog.2016.11.1029

No abstract available

Publication types

Letter
Comment

MeSH terms

Candidiasis, Vulvovaginal*
Female
Humans
Recurrence*
Risk Factors